Acquisition highlights of Sayre Therapeutics and a snapshot of its key metrics.

Founded in 2015, Sayre Therapeutics operates in Health Tech offering novel medicines, drug-delivery devices, companion diagnostics and diagnostic imaging agents to various oncologists and rheumatologists. The company focuses on developing small molecules, recombinant proteins, monoclonal antibodies, and diagnostics specifically in Oncology and Immunology. Sayre Therapeutics employs a business model that includes global access and early access programmes, as well as named patient programmes to facilitate product registrations for exclusive distribution in South Asia.

Shukrit Sudhir Chimote

Funding highlights of Sayre Therapeutics and a snapshot of its key metrics.

InnoVen Capital

Aarin Capital

Accel

Investment highlights of Sayre Therapeutics and a snapshot of its key metrics.

Sayre Therapeutics - A Health Tech Funded Company Based Out Of Bengaluru

Sayre Therapeutics

A snapshot of highlights, scale, and metrics

An overview of key people in Sayre Therapeutics.

A Health Tech Funded Company Based Out Of Bengaluru

Sayre Therapeutics - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More